$13.72
0.382.85%
At close: -
$13.98
0.261.90%
After Hours: Nov 22, 7:42 PM EDT
Day One Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Day One Biopharmaceutical using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $0.38 | $-0.41 | 192.7 % |
Jun 2024 | 2024-07-30 | $-0.05 | $-0.62 | 91.9 % |
Mar 2024 | 2024-05-06 | $-0.72 | $-0.66 | -9.09 % |
Dec 2023 | 2024-02-26 | $-0.64 | $-0.58 | -10.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $93.76M | $23.54M | 298.3 % |
Jun 2024 | 2024-07-30 | $8.19M | $1.02M | 703.1 % |
Day One Biopharmaceutical (DAWN) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $0.38, which beat the estimate of $-0.41.
The Actual Revenue was $93.8M, which beat the estimate of $23.5M.
Browse earnings estimates, EPS, and revenue on all stocks.